Given this complex metabolic and signaling network, it should come as no surprise that uric acid is also a key player in metabolic syndrome and obesity 8
Whether its through personalized nutrition, functional medicine testing, supplements, or advanced therapies, we help you achieve real results
Our team ensures that each patient receives personalized care and guidance for the best possible results
In short, researchers are strongly encouraged to become familiar with relevant findings on the best handling and administration protocols for specific uses of BPC-157, as optimal delivery methods are subject to change

Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy